Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 613

1.

The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.

Liang J, Mesplède T, Oliveira M, Anstett K, Wainberg MA.

J Virol. 2015 Nov;89(22):11269-74. doi: 10.1128/JVI.01881-15. Epub 2015 Aug 26.

PMID:
26311878
2.

SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.

Ayinde D, Bruel T, Cardinaud S, Porrot F, Prado JG, Moris A, Schwartz O.

J Virol. 2015 Jul;89(14):6994-7006.

3.

HIV-1 IN/Pol recruits LEDGF/p75 into viral particles.

Desimmie BA, Weydert C, Schrijvers R, Vets S, Demeulemeester J, Proost P, Paron I, De Rijck J, Mast J, Bannert N, Gijsbers R, Christ F, Debyser Z.

Retrovirology. 2015 Feb 12;12:16. doi: 10.1186/s12977-014-0134-4.

4.

HIV-1 integrase multimerization as a therapeutic target.

Feng L, Larue RC, Slaughter A, Kessl JJ, Kvaratskhelia M.

Curr Top Microbiol Immunol. 2015;389:93-119. doi: 10.1007/82_2015_439. Review.

PMID:
25778682
5.

Enzymatic synthesis of acyclic nucleoside thiophosphonate diphosphates: effect of the α-phosphorus configuration on HIV-1 RT activity.

Priet S, Roux L, Saez-Ayala M, Ferron F, Canard B, Alvarez K.

Antiviral Res. 2015 May;117:122-31. doi: 10.1016/j.antiviral.2015.03.003. Epub 2015 Mar 9.

PMID:
25766862
6.

Degradation of SAMHD1 by Vpx Is Independent of Uncoating.

Jáuregui P, Logue EC, Schultz ML, Fung S, Landau NR.

J Virol. 2015 May;89(10):5701-13. doi: 10.1128/JVI.03575-14. Epub 2015 Mar 11.

7.

Retroviral Integrase Structure and DNA Recombination Mechanism.

Engelman A, Cherepanov P.

Microbiol Spectr. 2014;2(6):1-22.

8.

Synthesis, biological evaluation and molecular docking of calix[4]arene-based β-diketo derivatives as HIV-1 integrase inhibitors.

Luo Z, Zhao Y, Ma C, Li Z, Xu X, Hu L, Huang N, He H.

Arch Pharm (Weinheim). 2015 Mar;348(3):206-13. doi: 10.1002/ardp.201400390. Epub 2015 Feb 10.

PMID:
25682937
9.

HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.

Daniels SM, Sinck L, Ward NJ, Melendez-Peña CE, Scarborough RJ, Azar I, Rance E, Daher A, Pang KM, Rossi JJ, Gatignol A.

RNA Biol. 2015;12(2):123-35. doi: 10.1080/15476286.2015.1014759.

PMID:
25668122
10.

Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutions.

Anstett K, Mesplede T, Oliveira M, Cutillas V, Wainberg MA.

J Virol. 2015 Apr;89(8):4681-4. doi: 10.1128/JVI.03485-14. Epub 2015 Feb 4.

11.

Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Ritchie C, Cylinder I, Platt EJ, Barklis E.

J Virol. 2015 Apr;89(7):3988-4001. doi: 10.1128/JVI.03584-14. Epub 2015 Jan 28.

12.

Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase.

Sangeetha B, Muthukumaran R, Amutha R.

J Comput Aided Mol Des. 2015 Apr;29(4):371-85. doi: 10.1007/s10822-015-9830-y. Epub 2015 Jan 14.

PMID:
25586721
13.

Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.

Jayappa KD, Ao Z, Wang X, Mouland AJ, Shekhar S, Yang X, Yao X.

J Virol. 2015 Apr;89(7):3497-511. doi: 10.1128/JVI.03347-14. Epub 2015 Jan 7.

14.

Host factors for retroviral integration site selection.

Debyser Z, Christ F, De Rijck J, Gijsbers R.

Trends Biochem Sci. 2015 Feb;40(2):108-16. doi: 10.1016/j.tibs.2014.12.001. Epub 2014 Dec 31. Review.

PMID:
25555456
15.

Kinetic variations between reverse transcriptases of viral protein X coding and noncoding lentiviruses.

Lenzi GM, Domaoal RA, Kim DH, Schinazi RF, Kim B.

Retrovirology. 2014 Dec 19;11:111. doi: 10.1186/s12977-014-0111-y.

16.

Design, synthesis, and biological evaluation of novel 2H-pyran-2-one derivatives as potential HIV-1 reverse transcriptase inhibitors.

Defant A, Mancini I, Tomazzolli R, Balzarini J.

Arch Pharm (Weinheim). 2015 Jan;348(1):23-33. doi: 10.1002/ardp.201400235. Epub 2014 Dec 19.

PMID:
25523431
17.

HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.

Chamontin C, Rassam P, Ferrer M, Racine PJ, Neyret A, Lainé S, Milhiet PE, Mougel M.

Nucleic Acids Res. 2015 Jan;43(1):336-47. doi: 10.1093/nar/gku1232. Epub 2014 Dec 8.

18.

Targeting HIV-1 integrase with strand transfer inhibitors.

Li Y, Xuan S, Feng Y, Yan A.

Drug Discov Today. 2015 Apr;20(4):435-49. doi: 10.1016/j.drudis.2014.12.001. Epub 2014 Dec 6. Review.

PMID:
25486307
19.

Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant.

Qamar Saeed M, Dufour N, Bartholmae C, Sieranska U, Knopf M, Thierry E, Thierry S, Delelis O, Grandchamp N, Pilet H, Ravassard P, Massonneau J, Pflumio F, von Kalle C, Lachapelle F, Bemelmans AP, Schmidt M, Serguera C.

Mol Ther Nucleic Acids. 2014 Dec 2;3:e213. doi: 10.1038/mtna.2014.65.

20.

A study of effects of peptide fragments of bovine and human lactoferrins on activities of three key HIV-1 enzymes.

Wong JH, Liu Z, Law KW, Liu F, Xia L, Wan DC, Ng TB.

Peptides. 2014 Dec;62:183-8.

PMID:
25445609
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk